Nucleophosmin Mutants Promote Adhesion, Migration and Invasion of Human Leukemia THP-1 Cells through MMPs Up-regulation via Ras/ERK MAPK Signaling

Jingrong Xian, Hui-Yuan Shao, Xianchun Chen, Shuaishuai Zhang, Jing Quan, Qin Zou, Hongjun Jin, Ling ZhangInternational Journal of Biological Sciences 2015 · DOI

Abstract

Acute myeloid leukemia (AML) with mutated nucleophosmin (NPM1) is a distinct clinical subgroup often characterized by extramedullary infiltration (EMI). However, the mechanisms driving this invasive behavior have remained unclear. This study demonstrates that overexpression of the NPM1-mA mutation enhances the adhesive, migratory, and invasive potential of THP-1 AML cells. This phenotype is driven by the up-regulation of matrix metalloproteinases (MMP-2 and MMP-9) and the down-regulation of their inhibitor, TIMP-2. Mechanistically, NPM1-mA interacts with K-Ras to activate the Ras/ERK MAPK signaling pathway. Inhibition of ERK, but not other MAPK pathways, reversed the invasive phenotype. Clinical data from TCGA further support the link between high MMP-2 expression and skin infiltration in NPM1-mutated AML patients.

Introduction

Acute Myeloid Leukemia (AML) patients with mutations in the Nucleophosmin (NPM1) gene frequently present with extramedullary infiltration (EMI), where leukemic cells invade tissues outside the bone marrow, such as the skin or gums. While this clinical association is well-documented, the molecular drivers of this increased motility and invasiveness have not been fully elucidated. This study aimed to identify the signaling pathways hijacked by NPM1 mutants to promote leukemia cell dissemination.

Experimental Approach

The researchers utilized THP-1 cells, a human monocytic leukemia line, engineered to overexpress either wild-type NPM1 or the common NPM1-mA mutation. The study employed functional assays (Transwell and Matrigel) to assess migration and invasion, biochemical techniques (Western blotting, Immunoprecipitation) to map signaling cascades, and gelatin zymography to measure the activity of matrix-degrading enzymes. Additionally, the team validated their findings using RNA-seq data from The Cancer Genome Atlas (TCGA), comparing 165 AML patient samples.

Key Findings

NPM1-mA Specifically Drives Invasiveness, Not Proliferation

A critical observation was that while the NPM1-mA mutation significantly increased the cells' ability to adhere and invade, it did not substantially alter their growth rate.

Figure 1: Cell proliferation assay showing similar growth rates across untreated, control vector (pEGFPC1), NPM1-wt, and NPM1-mA groups over two days.

As shown in the proliferation assay, the growth curves for all experimental groups are nearly identical, suggesting that the mutation specifically targets the cellular machinery responsible for movement and tissue degradation rather than simply increasing cell numbers.

Activation of the Ras/ERK Pathway and MMP Up-regulation

The study found that mutant NPM1 physically interacts with K-Ras, triggering the ERK/MAPK signaling axis. This activation leads to a dual effect: the up-regulation of "cellular scissors"—the enzymes MMP-2 and MMP-9—and the down-regulation of TIMP-2, a natural inhibitor of these enzymes.

Figure 4: Representative images of cell adhesion/invasion assays showing increased cell density in the NPM1-mA group compared to controls.

By increasing the production of matrix-degrading enzymes while simultaneously removing their "brakes," NPM1-mA enables leukemia cells to efficiently break through the extracellular matrix and infiltrate distant organs. This phenotypic change is clearly visible in adhesion assays, where NPM1-mA cells show significantly higher density.

Clinical Implications and Conclusion

Analysis of the TCGA dataset confirmed that MMP-2 expression is significantly higher in patients with NPM1 mutations and correlates strongly with clinical cases of skin infiltration. These results provide a molecular explanation for the aggressive tissue invasion seen in this AML subtype. Future therapeutic strategies might focus on inhibiting the ERK/MAPK pathway or targeting MMP activity to prevent the complications associated with extramedullary disease.

Summary updated

Abstract

Acute myeloid leukemia (AML) with mutated nucleophosmin (NPM1) has been defined as a unique subgroup in the new classification of myeloid neoplasm, and the AML patients with mutated NPM1 frequently present extramedullary infiltration, but how NPM1 mutants regulate this process remains elusive. In this study, we found that overexpression of type A NPM1 gene mutation (NPM1-mA) enhanced the adhesive, migratory and invasive potential in THP-1 AML cells lacking mutated NPM1. NPM1-mA had up-regulated expression and gelatinolytic matrix metalloprotease-2 (MMP-2)/MMP-9 activity, as assessed by real-time PCR, western blotting and gelatin zymography. Following immunoprecipitation analysis to identify the interaction of NPM1-mA with K-Ras, we focused on the effect of NPM1-mA overexpression on the Ras/Mitogen-activated protein kinase (MAPK) signaling axis and showed that NPM1-mA increased the MEK and ERK phosphorylation levels, as evaluated by western blotting. Notably, a specific inhibitor of the ERK/MAPK pathway (PD98059), but not p38/MAPK, JNK/MAPK or PI3-K/AKT inhibitors, markedly decreased the cell invasion numbers in a transwell assay. Further experiments demonstrated that blocking the ERK/MAPK pathway by PD98059 resulted in reduced MMP-2/9 protein levels and MMP-9 activity. Additionally, NPM1-mA overexpression had down-regulated gene expression and protein production of tissue inhibitor of MMP-2 (TIMP-2) in THP-1 cells. Furthermore, evaluation of gene expression data from The Cancer Genome Atlas (TCGA) dataset revealed that MMP-2 was overexpressed in AML patient samples with NPM1 mutated and high MMP-2 expression associated with leukemic skin infiltration. Taken together, our results reveal that NPM1 mutations contribute to the invasive potential of AML cells through MMPs up-regulation via Ras/ERK MAPK signaling pathway activation and offer novel insights into the potential role of NPM1 mutations in leukemogenesis.
BibTeX
@article{xian2015nucleophosmin,
  author = {Jingrong Xian and Hui-Yuan Shao and Xianchun Chen and Shuaishuai Zhang and Jing Quan and Qin Zou and Hongjun Jin and Ling Zhang},
  title = {{Nucleophosmin Mutants Promote Adhesion, Migration and Invasion of Human Leukemia THP-1 Cells through MMPs Up-regulation via Ras/ERK MAPK Signaling}},
  journal = {International Journal of Biological Sciences},
  year = {2015},
  doi = {10.7150/ijbs.13382},
}
Figure